Details for 2018730908

Up to date per 01.04.2026

Actions

Title / Product Name

DULAGLUTID ZUR BEHANDLUNG VON CHRONISCHER NIERENERKRANKUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018730908

EP Publication Number

3630164

E-Number

1601795

Language

PCT Number

US18034278

Publication Date

08.04.2020 A

23.08.2023 B1

Registration Date

23.08.2023

AT Publication Date

15.09.2023

Application Date

24.05.2018

Registration Number

Priorities

01.06.2017

201762513556 P

IPC

A61K 38/26 20060101AFI20230321BHEP

Maximum Duration of Protection

24.05.2038

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

BOTROS, Fady Talaatc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

LAKSHMANAN, Mark Chandrakantc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

TUTTLE, Katherine Rosec/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

ZIMMERMANN, Alan Georgec/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

Information about Fees